Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report

Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report

Chronic recurrent multifocal osteomyelitis (CRMO) is a rare autoinflammatory disease, clinically characterized by chronic and recurrent episodes of osteoarticular inflammation, that generally presents in children and adolescents. From a dermatological point-of-view, CMRO can be associated with skin...

Full description

Bibliographic Details
Main Authors: Maurizio Romagnuolo, Chiara Moltrasio, Claudia Iannone, Maurizio Gattinara, Stefano Cambiaghi, Angelo Valerio Marzano
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Medicine
Subjects:
pyoderma gangrenosum
chronic recurrent multifocal osteomyelitis
drug-induced PG
anti-TNF
adalimumab
adverse drug reaction
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1197273/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1197273/full

Similar Items